BioSig Technologies: Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites

Press/Media: Expert Comment

PeriodJul 13 2020

Media coverage

1

Media coverage

  • TitleBioSig Technologies: Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date7/13/20
    PersonsCheng Huang, John Manning
View all 1
View less

Keywords

  • COVID-19